The incumbent will be responsible for QC activities as per international regulatory guidelines. The job will require in-depth knowledge and sound understanding of various analytical techniques and cGMP, GLP principles. Incumbent must have hands on experience of QC activities at plants in the area of drug formulations.
Summary
Experience:
6 - 10 Years
Location:
Paonta sahib
Education:
UG - B.Sc - Any SpecializationPG - M.Sc - Chemistry
Industry Type:
Pharma/ Biotech/Clinical Research
Role:
QA/QC Exec.
Functional Area:
Production, Maintenance, Quality
Posted Date:
13 Apr
Desired Candidate Profile
The candidate should be an M.Sc in Chemistry with 6-10 years experience in the pharmaceutical industry in the QC function. Should possess team skills along with good interpersonal & communication skills. Candidate should be willing to relocate to Paonta Sahib.
Job Description
The incumbent will be responsible for QC activities as per international regulatory guidelines. The job will require in-depth knowledge and sound understanding of various analytical techniques and cGMP, GLP principles. Incumbent must have hands on experience of QC activities at plants in the area of drug formulations.
Keywords: Quality control, MSc, Chemistry
Company Profile
Ranbaxy is a progressive and quality conscious multi-national organization serving the pharmaceutical needs of diverse markets around the globe comprising of developing, emerging and advanced countries. It is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharma markets of the world. The Company with a global footprint in 49 countries, world-class manufacturing facilities in 11 and a diverse product portfolio, is rapidly moving towards global leadership, riding on its success in the worlds emerging and developed markets.Earlier in June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The transformational deal will place Ranbaxy in a higher growth trajectory. The ranking of the combined entity will be catapulted to the No. 15th position in the global pharmaceutical space and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing.
0 comments:
Post a Comment